Qivana, LLC – Trademark Portfolio

Entity Type: 16

Qivana, LLC holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 5 Nice Classification classes. The owner is based in Provo, UT.

5255 North Edgewood Drive

Provo, UT 84604

18 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Qivana, LLC's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (10 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (5 filings)

Advertising; business management; business administration; office functions

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Qivana, LLC have?

Qivana, LLC has 18 U.S. trademarks filed with the USPTO.

What trademark classes does Qivana, LLC file in?

Qivana, LLC files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Qivana, LLC's trademark registration success rate?

Qivana, LLC has a 0% trademark registration rate, with 0 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.